Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
06/2009
06/17/2009CN101460495A Novel compound having heterocyclic ring
06/17/2009CN101460494A Process for production of 4-substituted azetidinone derivatives
06/17/2009CN101460493A Heterocyclic Gpcr agonists
06/17/2009CN101460492A Benzimidazoles and their use for the treatemnt of diabetes
06/16/2009US7547800 Process for trans-4-amino-1-cyclohexanecarboxylic acid derivatives
06/16/2009US7547790 Optically active 4,4-di-substituted oxazolidine derivative and method for producing same
06/16/2009US7547782 Met kinase inhibitors
06/16/2009US7547779 Preparation of 1,6-disubstituted azabenzimidazoles as kinase inhibitors
06/16/2009US7547717 2-thioxo-4-imidazolines; angina, hypertension, congestive heart failure, myocardial ischemia, arrhythmia, diabetes, urinary incontinence, stroke, pain, brain injury, or neuronal disorders
06/16/2009US7547710 Such as (2E)-3-[3-(aminomethyl)-2-isobutyl-4-(4-methylphenyl)quinolin-6-yl]acrylamide; dipeptidyl peptidase IV inhibitors; diabetes, obesity, glucose intolerance
06/16/2009US7547702 Glycoprotein antagonist; anticholesterol agents; cardiovascular disorders; strokes; antiischemic agents
06/16/2009US7547696 Aminoquinoline derivatives and their use as adenosine A3 ligands
06/16/2009US7547695 Pyridopyrimidinones
06/16/2009US7547694 Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions
06/16/2009CA2452217C Hiv inhibiting pyrimidines derivatives
06/16/2009CA2202032C Agent for potentiating nerve growth factor activity containing 1,2-ethanediol derivative or salt thereof
06/11/2009WO2009073203A1 Trp-m8 receptor ligands and their use in treatments
06/11/2009WO2009072915A1 New salts and crystal forms
06/11/2009WO2009072649A1 4-arylphenyl derivative
06/11/2009WO2009072635A1 Method for amplifying hematopoietic stem cells using heterocyclic compound
06/11/2009WO2009071606A1 Organic compounds
06/11/2009WO2009071577A1 Oxadiazole derivatives and their use as nicotinic acetylcholine receptor modulators
06/11/2009WO2009071576A1 5-aryl-1,3,4-oxadiazole-2-amines as nicotinic acetylcholine receptor agonists
06/11/2009WO2009071535A1 Diaminopyridines for the treatment of diseases which are characterised by excessive or anomal cell proliferation
06/11/2009WO2009071509A1 1,2-disubstituted-4-benzylamino-pyrrolidine derivatives as cetp inhibitors useful for the treatment of diseases such as hyperli pidemia or arteriosclerosis
06/11/2009WO2009071477A1 Isoxazolo-pyridazine derivatives
06/11/2009WO2009071476A1 Isoxazolo-pyridine derivatives
06/11/2009WO2009071464A1 Isoxazolo-pyrazine derivatives
06/11/2009WO2009071449A1 Pyridylmethyl-sulfonamide compounds
06/11/2009WO2009071448A1 Pyridylmethyl-sulfonamide compounds
06/11/2009WO2009070869A1 Renin inhibitors
06/11/2009WO2009055289A3 Therapeutic substituted lactams
06/11/2009WO2009013212A3 Dual modulators of 5-ht2a and d3 receptors
06/11/2009WO2007083320A3 Conversion of aromatic diazonium salt to aryl hydrazine
06/11/2009US20090149514 Oxadiazoline ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
06/11/2009US20090149509 Peptidyl deformylase inhibitors used for inhibiting bacteria or preventing bacterial contamination of a cell culture medium; 2 (S)-hydroxy-3 (R)-[2 (S)-oxazol-2-yl-pyrrolidine-1-carbonyl)-heptanoic acid hydroxamide
06/11/2009US20090149463 Therapeutic agents
06/11/2009US20090149462 Process for purification of aprepitant
06/11/2009US20090149460 New Compounds
06/11/2009US20090149459 P38 inhibitors and methods of use thereof
06/11/2009US20090149457 1H-Thieno[2,3-c]Pyrazole Compounds Useful as Kinase Inhibitors
06/11/2009US20090149456 2-Pyrimidinyl Pyrazolopyridine ErbB Kinase Inhibitors
06/11/2009US20090149454 7-((6,7-bis(methyloxy)-4-quinolinyl)oxy)-N-(5 -methyl-3-isoxazolyl)-2,3-dihydro-4H-1,4-benzoxazine-4-carboxamide; for prophylaxis and treatment of diseases, such as VEGF mediated diseases; cancer
06/11/2009US20090149447 Novel M3 Muscarinic Acetylcholine Receptor Antagonists
06/11/2009US20090149444 Benzylamine analogues
06/11/2009US20090149439 Pyridylmethysulfone derivative
06/11/2009US20090149438 Pyrimidines as PLK inhibitors
06/11/2009CA2708050A1 Method for expanding hematopoietic stem cells using heterocyclic compound
06/11/2009CA2707821A1 Isoxazolo-pyridazine derivatives
06/11/2009CA2707653A1 Diaminopyridines for the treatment of diseases which are characterised by excessive or anomal cell proliferation
06/11/2009CA2707651A1 1,2-disubstituted-4-benzylamino-pyrrolidine derivatives as cetp inhibitors useful for the treatment of diseases such as hyperli pidemia or arteriosclerosis
06/11/2009CA2707648A1 Isoxazolo-pyridine derivatives
06/11/2009CA2707565A1 Renin inhibitors
06/11/2009CA2706990A1 Isoxazolo-pyrazine derivatives
06/11/2009CA2705722A1 Organic compounds
06/11/2009CA2705489A1 Pyridylmethyl-sulfonamide compounds
06/10/2009EP2067778A1 Quinoxaline derivative, and light emitting element, licht emitting device and electronic appliance using the same
06/10/2009EP2066688A2 Macrocyclic hcv inhibitors and their uses
06/10/2009EP2066663A1 Heterocyclic fxr binding compounds
06/10/2009EP2066662A2 Serine hydrolase inhibitors
06/10/2009EP2066661A2 Phosphodiesterase inhibitors
06/10/2009EP2066653A1 6-1h-imidazo-quinazoline and quinolines derivatives, new potent analgesics and anti-inflammatory agents
06/10/2009EP2066648A1 Substituted dimethylcyclobutyl compounds, their preparation and use in medicaments
06/10/2009EP2066647A1 Benzoxazoles and oxazolopyridines being useful as janus kinases inhibitors
06/10/2009EP2066637A1 Novel substituted bipyridine derivatives and their use as adenosine receptor ligands
06/10/2009EP1414797B9 Hepatitis c virus polymerase inhibitors with a heterobicylic structure
06/10/2009EP0854870B1 Substituted imidazoles having anti-cancer and cytokine inhibitory activity
06/10/2009CN101450945A Method for producing furazolidone large particle crystal
06/10/2009CN101450944A Furazolidone synthesis and purification method
06/10/2009CN101450934A Sulfonyl-derivatives as novel inhibitors of histone deacetylase
06/09/2009US7544835 Carboxylic acid derivative and salt thereof
06/09/2009US7544810 Reacting an organic amine compound with a carbamyl-group-containing amide compound in the presence of a suitable polar or nonpolar aprotic, substantially anhydrous solvent or mixtures thereof; used as therapeutic agents for IMPDH-mediated diseases
06/09/2009US7544808 9-[4-[4-[[2-(2,2,2-trifluoroethoxy)benzoyl]amino]-1-piperidinyl]butyl]-N-(2,2,2-trifluoroethyl)-9H-fluorene-9-carboxamide; non-steroidal modulator of the glucocorticoid receptor, AP-1, and/or NF- kappa B activity, obesity, diabetes, inflammatory and immune diseases
06/09/2009US7544806 Piperidine-substituted indoles-or heteroderivatives thereof
06/09/2009US7544708 To treat diseases of respiratory, urinary and gastrointestinal systems; highly selective; significant potency; (2R,2S)(1 alpha ,5 alpha ,6 alpha )-N-{-[4-(1,3-dioxo-1,3-dihydro-isoindol-2-yl)-butyl]-3-azabicyclo[3.1.0]hex-6-yl-methyl}-2-hydroxy-2-cyclopentyl-2-phenylacetamide
06/09/2009US7544704 Aryl-4-ethynyl-isoxazole derivatives
06/09/2009US7544703 N-(3,5-Dimethylphenyl)-2-[2-(4-methylpiperazin-1-yl)pyridin-4-ylmethylthio]pyridine-3-carboxamide; 2-(2-Cyclopropylaminopyridin-4-ylmethylthio)-N-(3,5-dimethylphenyl)pyridine-3-carboxamide; cancer, rheumatoid arthritis, age-related macular degeneration, diabetic retinopathy, retinopathy of prematurity
06/09/2009US7544702 Bisaryl-sulfonamides
06/09/2009US7544700 4-chloro-N-((5-((4-(hexylamino)piperidin-1-yl)sulfonyl)thien-2 -yl)methyl)benzamide for example; JUN kinase inhibitors to treat nervous system disorders, cancer, cardiovascular and autoimmune disorders
06/09/2009US7544690 MCH receptor antagonists
06/09/2009US7544688 Hetereoaryl nitrile derivatives
06/09/2009US7544687 (2S)-3-{4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)-ethoxy]-phenyl}-2-(4-m-tolyl-piperazin-1-yl)-propionic acid; hyperglycemia, dyslipidemia, type II diabetes mellitus; (2S)-2-[4-(4-nitro-benzenesulfonyl)-piperazin-1-yl]-3-{4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)-ethoxy]-phenyl}-propionic acid;
06/09/2009CA2583764C Thrombopoietin activity modulating compounds and methods
06/04/2009WO2009069828A1 Agent for improving motor complications or psychiatric symptoms in parkinson's disease
06/04/2009WO2009069736A1 Nitrogenated compound
06/04/2009WO2009068682A2 Phenyl-oxetanyl-derivatives
06/04/2009WO2009068509A1 Novel benzamide derivatives useful as potassium channel modulators
06/04/2009WO2009068468A2 Pyridine compounds
06/04/2009WO2009068214A2 Heteroaryl-substituted piperidines
06/04/2009WO2009067960A2 A method of manufacturing (3r,4s)-l-(4-fluorophenyl)-3-[(3s)-3-(4-fluorophenyl)-3- hydroxypropyl)]-4-(4-hydroxyphenyl)-2-azetidinone and its intermediates
06/04/2009WO2009040314A3 Novel heteroaryl-substituted acetone derivatives, suitable for inhibiting phospholipase a2
06/04/2009WO2009038879A3 Stem cell differentiating agents and uses therefor
06/04/2009WO2009004427A3 Benzimidazole derivatives
06/04/2009US20090143583 Transfection reagents
06/04/2009US20090143579 Heterocyclic Inhibitors of MEK and Methods of Use Thereof
06/04/2009US20090143575 Vanilloid receptor ligands and their use in treatments
06/04/2009US20090143449 Bi-Aryl or Aryl-Heteroaryl Substituted Indoles
06/04/2009US20090143443 Cyclic amine compound and pest control agent
06/04/2009US20090143439 New pyridines as fbpase inhibitors for treatment of diabetes
06/04/2009US20090143422 P38 inhibitors and methods of use thereof
1 ... 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 ... 647